FDA Inspection 1121122 — Doris Staab, M.D.
The FDA completed an inspection of Doris Staab, M.D. on February 13, 2020 in Berlin. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 13, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Berlin (Germany)
Additional Details
Clinical Investigator (CI)